From April 11 to 14, 2018, the 79th CMEF Medical Expo and ICMD Medical Device Design and Manufacturing Exhibition was held at the Shanghai National Convention and Exhibition Center. Fujifilm (China) Investment Co., Ltd. (hereinafter referred to as "Fuji Film (China)") Amulet Innovality micro-dose multi-function breast tomography system was released, and the new product follows the excellent performance of Fujifilm's “clear diagnosis and health, accompanied by healthâ€. eyeball.
Photo: Fujifilm (China) Investment Co., Ltd. Vice President Shallow Fen (also left), Medical Systems Division Minister Hashimoto (right) unveiled Amulet Innovality micro-dose multi-function breast tomography system
According to the latest epidemiological data, the average age of onset of breast cancer in large cities in China is around 45 years old, which is about 10 years younger than developed countries in Europe and America. It is estimated that by 2030, the proportion of breast cancer patients over 65 years old in China will account for 27% of the total number of patients with breast diseases. Fortunately, breast cancer, as a superficial organ tumor, can achieve "non-cancer prevention" through self-examination and screening. Experts say that women over the age of 40 need to have a mammogram on a regular basis. [i] The birth of "Xingyi · Hyun" brought the gospel to the early diagnosis and timely treatment of female breast cancer.
The new generation Fuji "Stars and Hyun" breast DR system has excellent performance in terms of technical performance, convenient operation and patient experience:
First of all, in terms of improving image quality, "Xingyi · Hyun" is equipped with Fuji's latest fourth-generation HCP (Hexagonal Close Pattern) honeycomb flat panel detector, which realizes high-definition image display of 50μm and greatly improves DQE (Detective Quantum Efficiency) ensures the high efficiency of the entire inspection process from exposure to image display.
Secondly, in terms of high-precision positioning and diagnosis of lesions, "Xingyi · Hyun" uses dual-mode three-dimensional tomography Digital Breast Tomosynthesis, combined with tomosynthesis two-dimensional high-definition image S-view, can clearly display the overall structure of the breast and lesion distribution. It can realize high-precision layered observation of the internal tissue structure of the breast, and provides a two-dimensional image for the physician to freely select, and only needs one photography to generate two image modes, which can meet various clinical needs. Its tomographic biopsy puncture system Tomo Biopsy is also eye-catching, fully automatic remote positioning and ±7.5o, ±20o two large-scale biopsy angles, can clearly show the hidden lesions that traditional puncture can not identify, to achieve more accurate and faster One-click positioning.
The system has recently obtained CFDA certification for two high-end technologies: “two-dimensional image of tomosynthesis†and “three-dimensional biopsy of faultsâ€. The three-dimensional biopsy of faults is the first CFDA-certified device in the industry.
Secondly, in terms of high-precision positioning and diagnosis of lesions, "Xingyi·Hyun" uses dual-mode three-dimensional tomography Digital Breast Tomosynthesis, combined with tomosynthesis two-dimensional high-definition image S-view, can clearly display the overall structure of the breast and lesion distribution. It can realize high-precision layered observation of the internal tissue structure of the breast, and provides a two-dimensional image for the physician to freely select, and only needs one photography to generate two image modes, which can meet various clinical needs. Its tomographic biopsy puncture system Tomo Biopsy is also eye-catching, fully automatic remote positioning and ±7.5o, ±20o two large-scale biopsy angles, can clearly show the hidden lesions that traditional puncture can not identify, to achieve more accurate and faster One-click positioning.
The system has recently obtained CFDA certification for two high-end technologies: “two-dimensional image of tomosynthesis†and “three-dimensional biopsy of faultsâ€. The three-dimensional biopsy of faults is the first CFDA-certified device in the industry.
In terms of optimizing the irradiation dose, compared with the traditional AEC technology, Fuji's original iAEC technology can accurately calculate the exposure parameters, automatically identify the prosthesis in the breast, identify the gland area, and avoid manual operation by the physician, according to different breast types. The optimal radiation dose is determined, the radiation dose is further reduced, and the inspection process is optimized.
The new product also took a lot of thoughts on the patient experience, reflecting humanized care. The warm-toned flexible light provides a more relaxed examination environment for the patient, and the multi-dimensional adaptive compression plate also greatly reduces the inspection discomfort, resulting in improved overall comfort.
Fujifilm's "Stars Action" helps clinicians practice "eyes"
Fujifilm (China) teamed up with the Breast Cancer Professional Committee of the Chinese Medical Association's Radiology Branch to conduct a public health training program for breast diagnostics doctors---"Xingyi Action" in the first phase of 2018 also kicked off recently, and the new products are flying together. The "Stars Action" public welfare training course combines theoretical knowledge and clinical case readings to provide an excellent opportunity for on-site case studies and exchanges for physicians in the radiology medical and oncology clinics. Since its inception in 2017, Starburst has helped more than 500 breast diagnosticians from Beijing, Hangzhou, Wuhan, Fuzhou and Qingdao to update their knowledge and contribute to improving their clinical diagnostics.
It is reported that this year, "Stars Action" will conduct five classes in various regions of the country, through on-site lectures and live broadcasts, and strive to radiate to all parts of the country, to learn and share with the majority of breast diagnosticians, to provide patients with more professional Guide, aim to achieve the technical improvement and popularization of early diagnosis and treatment of breast cancer.
Fujifilm "Breast Cancer Care Charity" Ten Years of Progress
Fujifilm (China) has always been concerned about the health of Chinese women. This year is the eleventh year of Fujifilm (China) to open breast cancer care activities. Fujifilm (China) continues its pink ribbon campaign with the goal of “early detection, early diagnosis and early treatment†in the “Breast Cancer Prevention Month†in October each year, and organizes various forms of public welfare activities in accordance with the current situation of the domestic society. It is a healthy walk, a public welfare lecture, or a form of activity such as breast diagnosis, "helping pink baby, flying pink dream", etc., all of which make more people pay attention to the importance of breast health.
In the future, Fujifilm (China) will continue to serve more and more hospitals and breast diagnostic radiologists through technical research and development and public welfare training programs to help improve the diagnosis of breast cancer in China and protect the health of Chinese women.
Product categories of Geomembrane Welding Machine, we are specialized manufacturers from China, Geomembrane Hdpe Liner Welding Machine, Waterproofing Hdpe Geomembrane Welding Machine suppliers/factory, wholesale high-quality machine of Geomembrane welding R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
Geomembrane Welding Machine,Geomembrane Hdpe Liner Welding Machine,Waterproofing Hdpe Geomembrane Welding Machine,Hdpe Geomembrane Welding Machine
Wuxi DIZO Ultrasonic Technology Company , https://www.dizosonic.com